176 related articles for article (PubMed ID: 19128241)
1. Effects of HCV co-infection on apoptosis of CD4+ T-cells in HIV-positive patients.
Körner C; Krämer B; Schulte D; Coenen M; Mauss S; Fätkenheuer G; Oldenburg J; Nattermann J; Rockstroh JK; Spengler U
Clin Sci (Lond); 2009 May; 116(12):861-70. PubMed ID: 19128241
[TBL] [Abstract][Full Text] [Related]
2. HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals.
Rallón NI; Soriano V; Restrepo C; García-Samaniego J; Labarga P; López M; Peris A; González-Lahoz J; Benito JM
J Acquir Immune Defic Syndr; 2011 May; 57(1):1-8. PubMed ID: 21786458
[TBL] [Abstract][Full Text] [Related]
3. Impact of hepatitis C virus co-infection on HIV patients before and after highly active antiretroviral therapy: an immunological and clinical chemistry observation, Addis Ababa, Ethiopia.
Taye S; Lakew M
BMC Immunol; 2013 May; 14():23. PubMed ID: 23679118
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C coinfection enhances sensitization of CD4(+) T-cells towards Fas-induced apoptosis in viraemic and HAART-controlled HIV-1-positive patients.
Körner C; Tolksdorf F; Riesner K; Krämer B; Schulte D; Nattermann J; Rockstroh JK; Spengler U
Antivir Ther; 2011; 16(7):1047-55. PubMed ID: 22024520
[TBL] [Abstract][Full Text] [Related]
5. Influence of hepatitis C virus coinfection on CD4⁺ T cells of HIV-infected patients receiving HAART.
Shmagel KV; Saidakova EV; Korolevskaya LB; Shmagel NG; Chereshnev VA; Anthony DD; Lederman MM
AIDS; 2014 Oct; 28(16):2381-8. PubMed ID: 25111083
[TBL] [Abstract][Full Text] [Related]
6. CD4⁺ and CD8⁺ regulatory T cells (Tregs) are elevated and display an active phenotype in patients with chronic HCV mono-infection and HIV/HCV co-infection.
Hartling HJ; Gaardbo JC; Ronit A; Knudsen LS; Ullum H; Vainer B; Clausen MR; Skogstrand K; Gerstoft J; Nielsen SD
Scand J Immunol; 2012 Sep; 76(3):294-305. PubMed ID: 22671952
[TBL] [Abstract][Full Text] [Related]
7. T-lymphocyte populations in hepatitis C and HIV co-infected patients treated with interferon-alfa-2a and ribavirin.
Neau D; Galpérine T; Legrand E; Pitard V; Neau-Cransac M; Moreau JF; Ragnaud JM; Dupon M; Fleury H; Lafon ME
HIV Med; 2003 Apr; 4(2):120-6. PubMed ID: 12702132
[TBL] [Abstract][Full Text] [Related]
8. Impact of hepatitis C virus coinfection on immune restoration during successful antiretroviral therapy in chronic human immunodeficiency virus type 1 disease.
Santin M; Mestre M; Shaw E; Barbera MJ; Casanova A; Niubo J; Bolao F; Podzamczer D; Gudiol F
Eur J Clin Microbiol Infect Dis; 2008 Jan; 27(1):65-73. PubMed ID: 17938979
[TBL] [Abstract][Full Text] [Related]
9. T cell receptor excision circles (TRECs), CD4+, CD8+, and their CD45RO+, and CD45RA+, subpopulations in hepatitis C virus (HCV)-HIV-co-infected patients during treatment with interferon alpha plus ribavirin: analysis in a population on effective antiretroviral therapy.
Arizcorreta A; Márquez M; Fernández-Gutiérrez C; Guzmán EP; Brun F; Rodríguez-Iglesias M; Girón-González JA
Clin Exp Immunol; 2006 Nov; 146(2):270-7. PubMed ID: 17034579
[TBL] [Abstract][Full Text] [Related]
10. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells.
Al-Harthi L; Voris J; Du W; Wright D; Nowicki M; Frederick T; Landay A; Kovacs A
J Infect Dis; 2006 May; 193(9):1202-10. PubMed ID: 16586355
[TBL] [Abstract][Full Text] [Related]
12. Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy.
Zaegel-Faucher O; Bregigeon S; Cano CE; Obry-Roguet V; Nicolino-Brunet C; Tamalet C; Dignat-George F; Poizot-Martin I
AIDS; 2015 Jul; 29(12):1505-10. PubMed ID: 26244390
[TBL] [Abstract][Full Text] [Related]
13. Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients.
Najafi Fard S; Schietroma I; Corano Scheri G; Giustini N; Serafino S; Cavallari EN; Pinacchio C; De Girolamo G; Ceccarelli G; Scagnolari C; Vullo V; d'Ettorre G
Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):319-329. PubMed ID: 29279268
[TBL] [Abstract][Full Text] [Related]
14. HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension.
Reiberger T; Ferlitsch A; Sieghart W; Kreil A; Breitenecker F; Rieger A; Schmied B; Gangl A; Peck-Radosavljevic M
J Viral Hepat; 2010 Jun; 17(6):400-9. PubMed ID: 19780945
[TBL] [Abstract][Full Text] [Related]
15. Evolution of hepatitis C virus in HIV coinfected patients under antiretroviral therapy.
Sede M; Parra M; Manrique JM; Laufer N; Jones LR; Quarleri J
Infect Genet Evol; 2016 Sep; 43():186-96. PubMed ID: 27234841
[TBL] [Abstract][Full Text] [Related]
16. Impact of Hepatitis C Virus on the Circulating Levels of IL-7 in HIV-1 Coinfected Women.
Kerzerho J; McIlvaine EJ; Anthony P; Mack WJ; Wang CH; Frederick T; Operskalski E; Chen Z; Al-Harthi L; Landay A; Young MA; Tien PC; Augenbraun M; Strickler HD; Akbari O; Golub ET; Sharp GB; Kovacs A
J Acquir Immune Defic Syndr; 2016 Feb; 71(2):172-80. PubMed ID: 26761519
[TBL] [Abstract][Full Text] [Related]
17. Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication.
Ciuffreda D; Comte D; Cavassini M; Giostra E; Bühler L; Perruchoud M; Heim MH; Battegay M; Genné D; Mulhaupt B; Malinverni R; Oneta C; Bernasconi E; Monnat M; Cerny A; Chuard C; Borovicka J; Mentha G; Pascual M; Gonvers JJ; Pantaleo G; Dutoit V
Eur J Immunol; 2008 Oct; 38(10):2665-77. PubMed ID: 18958874
[TBL] [Abstract][Full Text] [Related]
18. Impaired CD4⁺ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients.
Glässner A; Eisenhardt M; Kokordelis P; Krämer B; Wolter F; Nischalke HD; Boesecke C; Sauerbruch T; Rockstroh JK; Spengler U; Nattermann J
J Hepatol; 2013 Sep; 59(3):427-33. PubMed ID: 23665286
[TBL] [Abstract][Full Text] [Related]
19. Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART.
Kuntzen T; Tural C; Li B; Feldmann G; Kupfer B; Nischalke HD; Clotet B; Sauerbruch T; Rockstroh JK; Spengler U
AIDS; 2008 Jan; 22(2):203-10. PubMed ID: 18097222
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic characterization of lymphocytes in HCV/HIV co-infected patients.
Roe B; Coughlan S; Dean J; Lambert JS; Keating S; Norris S; Bergin C; Hall WW
Viral Immunol; 2009 Feb; 22(1):39-48. PubMed ID: 19210227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
